Business   

Ranbaxy to recall batches of anti-cholesterol drug from U.K.

NEW DELHI: The drug regulator of the U.K. has asked Indian pharmaceutical firm Ranbaxy to recall three batches of its anti-cholesterol tablets, Pravastatin, on failure to update safety warnings in its information leaflets.

As per information available on U.K.-based Medicines and Healthcare products Regulatory Agency (MHRA), it has asked Ranbaxy to recall three batches of Pravastatin 10 mg and 40 mg tablets.

The regulator said patient information leaflets (PILs) had not been updated to include approved safety warnings, some of which were mandatory and initiated by the European Medicines Agency (EMA).

It had also asked pharmacists to quarantine all remaining stock of the above batches and return it to the wholesaler from which it was purchased, it added.

Ranbaxy officials could not be reached for comments. — PTI

Printer friendly page  
Send this article to Friends by E-Mail

Stories in this Section

Recharging pre-paid mobiles virtually for free
Dongfang bags India, China orders
Direct selling industry turnover touches Rs.4,120 crore
Ranbaxy to recall batches of anti-cholesterol drug from U.K.
Tata Steel receives MAKE 2010 award
Bullion Rates

Copyright © 2010, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu